带血和外围血液衍生的调节性T细胞治疗:在1型糖尿病中的进展

Yuanjie Bi1, Ran Kong1, Yani Peng1

  • 1National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Hunan Engineering Research Center of Cell Therapy for Diabetes, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.

概括

调节性T细胞 (Tregs) 通过恢复免疫耐受性来治疗1型糖尿病 (T1D) 是有前途的. 然而,在临床应用和扩展中,对于有效的T1D治疗仍然存在挑战.